WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed Price. Currency in USD
111.52
-0.12 (-0.11%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close111.64
Open112.04
Bid0.00 x 1800
Ask0.00 x 900
Day's Range109.88 - 112.70
52 Week Range84.91 - 125.09
Volume379,805
Avg. Volume464,946
Market Cap8.223B
Beta (3Y Monthly)1.33
PE Ratio (TTM)40.70
EPS (TTM)2.74
Earnings DateApr 25, 2019
Forward Dividend & Yield0.60 (0.54%)
Ex-Dividend Date2019-04-16
1y Target Est112.40
Trade prices are not sourced from all markets
  • Does This Valuation Of West Pharmaceutical Services, Inc. (NYSE:WST) Imply Investors Are Overpaying?
    Simply Wall St.15 hours ago

    Does This Valuation Of West Pharmaceutical Services, Inc. (NYSE:WST) Imply Investors Are Overpaying?

    Today we'll do a simple run through of a valuation method used to estimate the attractiveness of West Pharmaceutical Services, Inc. (NYSE:WST) as an investment opportunity by taking the foreast future cash flows of the company and...

  • Is West Pharmaceutical Services Inc. (WST) A Good Stock To Buy?
    Insider Monkey3 days ago

    Is West Pharmaceutical Services Inc. (WST) A Good Stock To Buy?

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in […]

  • West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?
    Zacks4 days ago

    West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?

    West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree
    PR Newswire10 days ago

    West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree

    EXTON, Pa., April 12, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient. West received the honor for its ongoing support of Fox Chase Cancer Center during an awards breakfast on April 11, 2019. Organized by the Philadelphia Business Journal, the Faces of Philanthropy awards recognize Philadelphia-based companies who, through philanthropic initiatives with a non-profit organization, have made a large impact on the Philadelphia community through monetary donations, social impact and community involvement.

  • West to Host First-Quarter 2019 Conference Call
    PR Newswire11 days ago

    West to Host First-Quarter 2019 Conference Call

    EXTON, Pa., April 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019  financial results before the market opens on Thursday, April 25, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 7794502. An online archive of the broadcast will be available at the West website three hours after the live call and will be available through Thursday, May 2, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406  (International).

  • Markit13 days ago

    See what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.

    West Pharmaceutical Services Inc NYSE:WSTView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for WST with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting WST. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding WST are favorable with net inflows of $72.05 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Industrials sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • What Should We Expect From West Pharmaceutical Services, Inc.'s (NYSE:WST) Earnings In The Next 12 Months?
    Simply Wall St.18 days ago

    What Should We Expect From West Pharmaceutical Services, Inc.'s (NYSE:WST) Earnings In The Next 12 Months?

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Since West Pharmaceutical Services, Inc. (NYSE:WST) released its earnings in December 2018...

  • West Expands Presence in Korea with New Sales Office
    PR Newswire18 days ago

    West Expands Presence in Korea with New Sales Office

    SEOUL, South Korea, April 4, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea—West Pharmaceutical Services Korea Ltd. This new office is the result of West's purchase of the distribution business of GIS Korea Ltd., a privately-owned medical device and healthcare products distributor serving the Korean market, who previously served as West's distributor in the region. "We are excited to build upon the strong foundation that our distributor has established in Korea, as this is an important market for West and our customers," said Karen Flynn, Senior Vice President and Chief Commercial Officer, West.

  • West Opens New Digital Technology Center in Bengaluru, India
    PR Newswirelast month

    West Opens New Digital Technology Center in Bengaluru, India

    BENGALURU, India, March 8, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India, a regional hub of digital and technology talent. This state-of-the-art business space will serve as a global center of excellence for the Company's Digital and Transformation (D&T) team, alongside teams based in Exton, Pennsylvania, and Eschweiler, Germany.

  • What Should We Expect From West Pharmaceutical Services, Inc.’s (NYSE:WST) Earnings In The Next Couple Of Years?
    Simply Wall St.2 months ago

    What Should We Expect From West Pharmaceutical Services, Inc.’s (NYSE:WST) Earnings In The Next Couple Of Years?

    In December 2018, West Pharmaceutical Services, Inc. (NYSE:WST) released its most recent earnings announcement, which suggested that the business benefited from a robust tailwind, leading to a double-digit earnings growthRead More...

  • GlobeNewswire2 months ago

    Detailed Research: Economic Perspectives on The J. M. Smucker, West Pharmaceutical Services, Franklin Electric Co., Accenture, LiveXLive Media, and Otter Tail — What Drives Growth in Today's Competitive Landscape

    NEW YORK, Feb. 21, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • West Announces Quarterly Dividend and Share Repurchase Program
    PR Newswire2 months ago

    West Announces Quarterly Dividend and Share Repurchase Program

    EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per ...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of WST earnings conference call or presentation 14-Feb-19 2:00pm GMT

    Q4 2018 West Pharmaceutical Services Inc Earnings Call

  • West Pharmaceutical Services (WST) Beats Q4 Earnings Estimates
    Zacks2 months ago

    West Pharmaceutical Services (WST) Beats Q4 Earnings Estimates

    West Pharmaceutical (WST) delivered earnings and revenue surprises of 1.39% and -2.87%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press2 months ago

    West Pharmaceutical: 4Q Earnings Snapshot

    On a per-share basis, the Exton, Pennsylvania-based company said it had net income of 69 cents. Earnings, adjusted for pretax expenses and restructuring costs, were 73 cents per share. The results topped ...

  • West Announces Fourth-Quarter and Full-Year 2018 Results
    PR Newswire2 months ago

    West Announces Fourth-Quarter and Full-Year 2018 Results

    - Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter ...

  • Could West Pharmaceutical Services, Inc.’s (NYSE:WST) Investor Composition Influence The Stock Price?
    Simply Wall St.3 months ago

    Could West Pharmaceutical Services, Inc.’s (NYSE:WST) Investor Composition Influence The Stock Price?

    Want to participate in a short research study? Help shape the future of investing tools and receive a $60 prize! Every investor in West Pharmaceutical Services, Inc. (NYSE:WST) should be Read More...

  • West to Host Fourth-Quarter and Full-Year 2018 Conference Call
    PR Newswire3 months ago

    West to Host Fourth-Quarter and Full-Year 2018 Conference Call

    EXTON, Pa., Jan. 31, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2018 financial results before the market opens on Thursday, February 14, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 2287302. An online archive of the broadcast will be available at the West website three hours after the live call and through Thursday, February 21, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International).

  • Motley Fool3 months ago

    3 Pick-and-Shovel Biotechnology Stocks

    These biotech suppliers have performed extremely well for investors. Here's why each of them is poised for prosperity.